Guangzhou, China – September 29, 2025 – SonoStar, the world’s first manufacturer of AI-integrated ultrasound probes, has successfully participated in the 2025 Autumn China International Medical Equipment Fair (CMEF), held at the China Import and Export Fair Complex in Guangzhou from September 26 to 29. Aligned with this year’s CMEF theme “Health · Innovation · Sharing – Co-Creating a New Blueprint for Global Healthcare”, SonoStar’s cutting-edge ultrasound solutions have attracted extensive attention from healthcare professionals, distributors, and hospital procurement teams across nearly 20 countries and regions, further consolidating its influence in the Chinese and global medical imaging markets.

As a benchmark event in the global medical device industry, the 2025 Autumn CMEF covers an exhibition area of nearly 160,000 square meters, gathering over 3,000 exhibitors and expecting more than 120,000 professional attendees. The exhibition focuses on transformative trends such as AI+medical care, digital transformation, and intelligent technology application, with 28 thematic exhibition areas covering various medical fields. SonoStar’s booth became a key attraction, showcasing its flagship AI-integrated ultrasound probes that cover multiple clinical scenarios including MSK, urology, and thyroid detection. Live demonstrations highlighted the probes’ real-time high-resolution imaging capabilities and AI-assisted pathological identification functions, which effectively optimize diagnostic workflows and enhance clinical efficiency.

“CMEF provides an unparalleled platform for us to connect with global healthcare leaders and demonstrate how our AI-powered ultrasound technologies align with the development needs of precision medicine,” said a SonoStar representative at the exhibition. “Our focus on high quality, high technology, and high intelligence, as well as compliance with relevant domestic and international medical standards, has resonated strongly with attendees, especially those from the Chinese healthcare system and Southeast Asian markets.”

A key highlight of SonoStar’s participation was the in-depth discussions on clinical application scenarios and international cooperation opportunities. Many attendees showed strong interest in the company’s solutions, with several preliminary cooperation intentions signed with distributors from mainland China, Southeast Asia, and the Middle East. This not only strengthens SonoStar’s market penetration in the domestic market, especially in the Guangdong-Hong Kong-Macao Greater Bay Area, but also lays a solid foundation for further expanding its global market layout.

Beyond showcasing innovations, SonoStar actively participated in the 60+ professional forums and thematic meetings held during CMEF, sharing insights on the integration of AI technology in ultrasound equipment and exchanging views with industry peers on topics such as digital medical ecological construction and global healthcare collaboration. The company’s successful participation in the 2025 Autumn CMEF reaffirms its commitment to driving technological innovation in the global medical imaging industry and providing high-quality healthcare solutions to patients worldwide.

For more information on SonoStar’s innovations and 2025 Autumn CMEF highlights, please visit the company’s official website.

### About SonoStar SonoStar is dedicated to developing high-quality, high-tech, and highly intelligent medical imaging solutions. As the pioneer of AI-integrated ultrasound probes, the company strives to empower healthcare providers with advanced technologies to enhance diagnostic efficiency and improve patient outcomes. SonoStar continues to expand its international footprint and promote global healthcare collaboration through in-depth participation in major medical exhibitions around the world.